Continuing Education Activity

Lifestyle behaviors are key determinants of disease risk, longevity, and quality of life. Unhealthy habits, including poor diet, physical inactivity, smoking, and excessive alcohol use, contribute substantially to global morbidity and mortality, while adherence to healthy behaviors remains low. This activity reviews health-enhancing and health-compromising behaviors, major lifestyle domains linked to chronic disease, and the intention-behavior gap as a barrier to sustained change. Participants examine core behavior-change frameworks, including habit formation, motivational theories, and stage-based models, with attention to their clinical application and limitations. The activity also addresses common barriers to counseling, relapse, and nonadherence, and highlights patient-centered, individualized strategies and interprofessional support. Clinicians strengthen their ability to assess readiness for change, apply evidence-based counseling techniques, design realistic and sustainable interventions, and collaborate effectively to improve adherence, clinical outcomes, and long-term health.

Objectives:

• Identify the key health-compromising behaviors that contribute to chronic disease risk across diverse patient populations.
• Determine a patient’s position on the intention-behavior spectrum to guide appropriate intervention strategies.
• Implement phase-specific interventions that promote long-term behavior maintenance.
• Collaborate with interprofessional team members to support behavior modification strategies to enhance patient-centered care.

Introduction

Lifestyle plays a central role in disease risk and overall health. Numerous conditions are caused or worsened by unhealthy behaviors such as smoking, physical inactivity, excessive alcohol consumption, and poor dietary habits.[1] In 2017, unhealthy behaviors were estimated to account for over 23 million deaths and 36.5% of disability-adjusted life-years worldwide.[2] Health-compromising behaviors increase disease risk and reduce well-being.[2]

Although the importance of healthy behaviors is well established, adherence remains low across populations. In the United States, the proportion of adults adhering to 5 key health behaviors fell from 15% to 8% between 1988 and 2006.[3] Adherence to a healthy lifestyle has also been associated with substantial gains in life expectancy, estimated at 14.0 years for women and 12.2 years for men in the United States.[4] 

Public health agencies, healthcare professionals, and other organizations have increasingly promoted healthy habits through health promotion campaigns; however, the behavioral effects of these campaigns have remained modest and somewhat controversial.[5][6] Understanding the factors that influence behavior is essential for developing effective interventions. This activity focuses on clinically relevant behavior-change concepts used across lifestyle medicine domains, including readiness, self-efficacy, motivational interviewing, action planning, relapse prevention, and referral pathways.[7]

The Intention-Behavior Gap

A person's intention is the motivation to perform a behavior or attain a goal.[8] Even when behavior is voluntary, actions do not always align with intentions. Because health-compromising behaviors can be difficult to stop and health-promoting behaviors can be difficult to adopt, intention alone does not reliably predict change.[9] The intention-behavior gap is the difference between what a person plans to do and what they actually do. Whether intention leads to action depends on internal factors, such as beliefs, skills, and knowledge, and external factors, such as time, money, and social support.[8] 

Recognizing this gap helps clinicians understand why patients struggle with behavior change and encourages the use of strategies that improve adherence.[10] One practical bridge from intention to action is the use of implementation intentions, which are brief if-then plans that specify when, where, and how a behavior will occur. Meta-analyses support the use of implementation intentions to improve healthy dietary behaviors and increase physical activity.[11][12]

Issues of Concern

Numerous health-related behaviors have been documented in the medical literature.[13] In practice, much of the focus has been on a smaller group strongly associated with health outcomes, including diet quality, body weight, physical activity, smoking avoidance or cessation, and limiting alcohol consumption.[14] For this reason, interventions that prioritize behavior change in these areas are likely to affect many chronic noncommunicable diseases.

Diet Quality

Although some aspects of nutrition remain controversial, diet remains one of the strongest determinants of health and well-being. Whole-food, plant-based dietary patterns represent an evidence-based dietary approach to nutrition.[15][16] Studies have shown an association between diets high in saturated fat and higher levels of low-density lipoprotein and very low-density lipoprotein, both of which are linked to atherosclerotic cardiovascular disease.[17] Please see StatPearls' companion resource, "Biochemistry, Very Low Density Lipoprotein," for more information. Nutritional guidelines emphasize that adults in the United States consume excessive amounts of calories, saturated fats, sodium, and added sugars, while consuming insufficient amounts of fruits, vegetables, and whole grains.[18]

According to the United States Department of Agriculture, a health-promoting dietary pattern includes eating within calorie limits and prioritizing nutrient-dense foods and beverages. Recommendations include fruits, vegetables, legumes, whole grains, nuts, seeds, and nutrient-rich protein sources, while limiting added sugars, saturated fat, and sodium.[18] In clinical counseling, this often means focusing on practical first steps, such as increasing intake of minimally processed, fiber-rich foods and reducing intake of added sugars and ultra-processed foods.[16]

Body Weight and Body Mass Index

Although weight and body mass index (BMI) are biomarkers rather than behaviors in the traditional sense, they are often used as behavioral risk markers because they reflect energy balance over time.[2] Body weight and BMI are strongly associated with health outcomes, though they have limitations. A high BMI may reflect chronic excess energy intake, leading to adiposity, insulin resistance, and metabolic dysfunction.[19]

Abnormal BMI values can help identify health-compromising patterns, but interpretation still requires clinical judgment. BMI may misclassify individuals with high lean mass, such as athletes, and may fail to detect abnormal body composition in some patients with normal BMI, such as those with sarcopenia and excess adiposity. For the general population, maintaining a normal BMI is recommended.[19][14] Counseling is generally more effective when focused on behavior and when weight-stigmatizing language is avoided, as such language can reduce engagement and follow-up.

Physical Activity and Exercise

Exercise activates the body's stress systems and, over time, leads to beneficial physiologic adaptation.[20] Physical inactivity and sedentary behavior are associated with adverse health outcomes, and research demonstrates a strong inverse dose-response relationship between physical activity and cardiovascular disease.[21] Recommendations from the United States Department of Health and Human Services emphasize engaging in moderate-to-vigorous physical activity, increasing movement, and reducing sedentary time. Current guidelines also recognize that any activity is better than none, which is important in counseling, as even small increases in movement can make a difference.

Basic recommendations for adults in the United States include 150 to 300 minutes per week of moderate-intensity activity or 75 to 150 minutes per week of vigorous activity, ideally spread throughout the week. Guidelines also recommend muscle-strengthening activities involving major muscle groups on 2 or more days per week.[21] Patients with exertional chest pain, syncope or presyncope, unexplained dyspnea, or unstable cardiopulmonary disease should undergo medical evaluation before initiating vigorous exercise.

Moderate or No Alcohol Consumption

When alcohol use is high-risk or problematic, brief screening and structured pathways can improve identification and follow-up, such as AUDIT-C and SBIRT-style workflows, with referral and pharmacotherapy when indicated (refer to "Barriers to Behavioral Counseling" for more information on referral pathways).[22][23] Excessive alcohol consumption is a significant risk factor for disability and early death. However, the relationship between moderate alcohol consumption and health outcomes remains debated.[24] 

Although some studies' results have suggested benefits of drinking in moderation compared with complete abstinence, these findings have been questioned due to methodological concerns. Current health recommendations advise limiting daily alcohol intake to 2 drinks or fewer for men and 1 drink or fewer for women, emphasizing that drinking less alcohol is better for health.[14][18] Global burden analyses support the message that less alcohol is better, with the lowest risk at zero consumption for several outcomes.[25] Current guidelines also recommend abstinence from alcohol for certain individuals, such as during pregnancy.[18] 

Smoking tobacco is among the most health-damaging behaviors. Studies' results demonstrate that smoking has a well-established causal role in multiple diseases, including coronary artery disease, chronic obstructive lung disease, and cancer. Please see StatPearls' companion resource, "Nicotine Addiction and Smoking: Health Effects and Interventions," for more information

Smoking cessation has been a central theme among health promotion campaigns for decades. Recent studies' results have demonstrated decreased smoking rates resulting from financial, educational, and regulatory interventions.[14] Tobacco avoidance is a central component of a health-promoting lifestyle, and smoking cessation should be encouraged. Cessation success improves when structured behavioral support is combined with pharmacotherapy.

Health-Behavior Modification Theories

Research in behavioral medicine and psychology has led to the development of many theories intended to explain why people act, fail to act, or return to prior patterns.[26] More than 30 behavior modification theories have been documented.[26] These theories generally aim to explain the relationship among thoughts, beliefs, choices, and behaviors.[27]

Substantial overlap exists among these models, and no single theory has proved clearly superior in clinical practice. Many have been criticized for limited predictive power, variable performance in clinical trials, or insufficient guidance for evidence-based use.[27] For this reason, clinicians should view them as practical frameworks rather than rigid formulas. Commonly used constructs include perceived barriers, perceived behavioral control, self-efficacy, planning, cues, and relapse.[26][27] Clinical scenarios often align with these constructs and can guide patient-centered interventions to modify health behaviors and improve lifestyle.[26][28]   

Habit Formation

In psychology, habits are automatic actions triggered by contextual cues.[29] Common examples include washing hands after using the toilet or fastening a seatbelt after getting into a car. Habit-based strategies are attractive because once a behavior becomes automatic, it depends less on ongoing motivation.[29] Habit strength is shaped by repetition and consistency and may help behavior persist even under stress or time pressure.[30]

Habit formation is often described in 3 stages: initiation, in which the behavior and cue are established; learning, in which repetition strengthens the association; and stability, in which the behavior becomes automatic.[29] The time required varies widely by person and behavior. Although results from 1 study reported an average of 66 days, subsequent evidence indicates broad variability, with many habits taking weeks to months to become automatic.[31] In practice, useful strategies include choosing a small, specific behavior, linking it to a stable cue, and making it easy to repeat.

Self-Determination Theory

Self-determination theory proposes that the quality of motivation influences whether health behavior change is initiated and maintained. This theory distinguishes autonomous motivation, in which behavior is experienced as personally chosen or aligned with an individual’s values, from controlled motivation, in which behavior is driven primarily by pressure, guilt, rewards, or the avoidance of punishment.[13] Across multiple health behaviors, people are generally more likely to intend to change and follow through when motivation comes from personal values or choice rather than external pressure or reward. A recent meta-analysis suggests that self-determination theory–informed interventions can improve health behaviors, although the overall effect is modest.[32] In clinical practice, this model supports counseling that emphasizes patient choice, personally meaningful goals, and confidence-building rather than reliance on external pressure.

Reasoned Action and Planned Behavior Theories

The theory of reasoned action proposes that intention is the most immediate predictor of voluntary behavior. The theory of planned behavior later incorporated perceived behavioral control, which reflects how easy or difficult a person believes the behavior will be to perform.[8] In practice, this model helps explain why some patients genuinely want to change but struggle to follow through when they anticipate barriers, limited control, or low confidence.[8]

Health Belief Model

The health belief model proposes that individuals are more likely to change behavior when they believe they are at risk for a meaningful health problem, consider the consequences significant, believe the recommended action will help, and view the barriers as manageable.[33] In practice, this framework can help identify whether a patient is not changing because the problem does not feel personally relevant, the expected benefit is unclear, or the perceived barriers outweigh the likely gain. The model remains clinically useful as a simple framework, but its predictive power is limited, and it should not be used as a stand-alone explanation of behavior.[33]

Social Cognitive Theory

Social cognitive theory suggests that behavior is shaped by ongoing interaction among the individual, the behavior, and the surrounding environment. A central concept is self-efficacy, or confidence in one’s ability to perform a behavior, because individuals are more likely to act when they believe they can perform it successfully.[34] This framework is particularly helpful when a patient understands the value of change but lacks the skills, support, or circumstances needed to follow through. This theory also highlights that behavior change depends not only on motivation but also on whether the environment creates obstacles or supports action.Health Action Process Approach

The health action process approach (HAPA) is a social cognitive model that divides behavior change into motivational and volitional phases.[35] These constructs may be more strongly associated with health behavior than risk perception alone, and the model supports phase-specific interventions rather than a one-size-fits-all approach.[35] According to this model, intention formation during the motivational phase depends on a person's risk perception (perceived susceptibility to developing specific health conditions or outcomes), action self-efficacy (perceived capability to perform a particular behavior), and outcome expectations (perceived likelihood of obtaining desired results from the new behavior).

In the volitional phase, intention implementation is supported by action planning, coping planning, coping self-efficacy, and recovery self-efficacy, which help patients translate intention into action, address barriers, and resume the behavior after lapses.[35] The evidence suggests that HAPA constructs may be more strongly associated with health behavior than risk perception alone. The HAPA model, therefore, supports phase-specific interventions rather than a one-size-fits-all approach.[35]

The Transtheoretical Model of Change

The transtheoretical model of change categorizes individuals by their readiness to modify behavior and proposes that counseling should be matched to the stage.[27] Individuals are generally more likely to engage when the approach aligns with their current readiness. The stages of the transtheoretical model are summarized below (see Table 1).

Table

Table 1. Transtheoretical Model of Change.

Motivational Interviewing

Motivational interviewing is a separate, patient-centered counseling method that is often used alongside the transtheoretical model to explore ambivalence and support readiness for behavior change.[37]

Barriers to Behavioral Counseling

In routine practice, behavioral counseling is often limited by clinician-, patient-, and system-level barriers, including limited training, lack of practical counseling tools, competing clinical priorities, time pressure during visits, limited referral pathways, and inadequate reimbursement or institutional support for preventive care.[38][39] Because physicians often care for large numbers of patients under time constraints, effective counseling may require a team-based approach and, when appropriate, timely referral.

Relapse and Nonadherence

Relapse, or a temporary interruption of a desired behavior, is common and is usually better viewed as part of the process rather than as a failure.[40] Even when motivation is strong, illness, stress, competing responsibilities, holidays, and family disruptions can lead to lapses. When this occurs, patients should be encouraged to resume the behavior, reflect on the interruption, and identify practical strategies to reduce the likelihood of future relapse.[41]

Clinical Significance

Individualizing Lifestyle CounselingLifestyle improvement is central to the prevention and management of many common chronic medical conditions. In prediabetes, lifestyle intervention is a cornerstone of diabetes prevention, and in type 2 diabetes, lifestyle modification remains a core component of management across the disease course.[42][43] Behavior modification interventions are most effective when individualized to a patient’s medical condition, goals, readiness to change, and social, economic, and physical environment.[7] Healthcare teams should engage patients in collaborative, patient-centered discussions that identify barriers, such as cost, time constraints, or limited access to resources, and factors that may support change, such as enjoyment, social support, and confidence, so that the plan fits the patient’s circumstances and can be sustained over time.[37][44]

Motivational InterviewingMotivational interviewing can strengthen these conversations by helping clinicians explore ambivalence, clarify patient priorities, and support collaborative change.[37][45] In clinical settings, motivational interviewing has demonstrated benefits across a range of health behaviors and outcomes, including diet, weight-related outcomes, and certain cardiometabolic measures, although effect sizes vary by population and setting.[45] Core motivational interviewing skills are summarized by the acronym OARS: open-ended questions, affirmations, reflections, and summaries.[37]

Other Issues

Pharmacologic Support for Behavior Change

In certain clinical settings, behavior change may be supported by pharmacologic treatment. These therapies do not replace voluntary lifestyle improvement or behavioral counseling; however, they may reduce physiologic barriers, improve adherence, and increase the likelihood of sustained change in appropriately selected patients. Because these options remain underused in some settings, healthcare teams should be familiar with them and consider their use when behavioral strategies alone are insufficient or when the expected benefit is substantial.[46]

Weight Management

For some patients who are overweight or have obesity, pharmacologic therapy can meaningfully support lifestyle-based treatment and improve the likelihood of achieving clinically significant weight loss. These medications are best understood as adjuncts to dietary change, physical activity, and behavioral support, not as replacements for these interventions. In recent years, incretin-based therapies have changed the treatment landscape because of the degree of weight loss observed in clinical trials. This group includes glucagon-like peptide-1 receptor agonists and dual incretin agonists, with oral options expanding the range of available therapies. Even so, much of the published clinical experience in obesity care has focused on semaglutide.[47][48][49]

Semaglutide remains a useful example because it has been studied extensively in patients with obesity. In the STEP 1 trial, adults who were overweight or had obesity and received semaglutide 2.4 mg with lifestyle intervention lost a mean 14.9% of baseline body weight at 68 weeks, compared with 2.4% in the placebo plus lifestyle group, an estimated difference of 12.4 percentage points.[50] The weight loss observed with semaglutide appears to be driven largely by reduced appetite and lower energy intake, which may make it easier for some patients to initiate and sustain dietary changes. At the same time, these medications do not eliminate the need for behavior change. Patients still require a sustainable eating pattern, regular physical activity, and follow-up that addresses adherence and expectations over time.

In clinical practice, the decision to use pharmacologic therapy should be individualized, with attention to comorbidities, patient preference, route of administration, adverse effects, cost, and access. Newer agents, including oral options, are broadening the range of available therapies, although the amount of evidence and the depth of clinical experience vary by agent.[47][48][49] A whole-food, plant-based dietary pattern is another evidence-based option for weight management and, in some patients, may produce clinically meaningful weight loss without pharmacotherapy.[49][51] When this dietary pattern is maintained over time, it may also support more durable weight control, whereas weight regain after discontinuation of incretin-based therapy is common.[52] Direct comparisons between these approaches, however, remain limited.

Smoking Cessation

Smoking cessation remains one of the most important behavioral changes for long-term health, particularly for reducing cardiovascular risk.[53] At the same time, quitting can be difficult even for highly motivated patients, and early weight gain is common. For many patients, this concern becomes part of the challenge, either because it discourages a quit attempt or because it makes abstinence harder to maintain. Patients should be reassured that the health benefits of smoking cessation clearly outweigh the risks associated with short-term weight gain.[54][55][56]Behavioral support remains central, but pharmacologic treatment can improve quit rates and lower the risk of relapse. Varenicline helps reduce cravings and withdrawal symptoms and makes smoking less rewarding, while bupropion is also an effective option for smoking cessation.[46][57] In practice, counseling and pharmacotherapy often work best together, particularly for patients with prior failed quit attempts or more severe nicotine dependence.[58][37]

Alcohol CessationReducing or stopping alcohol use can be difficult to sustain without additional support. Although counseling and follow-up remain central, pharmacologic treatment may improve outcomes in selected patients. Even so, medications for alcohol use disorder remain underused in routine practice, with fewer than 1 in 10 potentially eligible patients receiving them in some reports.[59] Available pharmacologic options include naltrexone and acamprosate. Naltrexone can help reduce heavy drinking by diminishing the rewarding effects of alcohol, while acamprosate is used mainly to support abstinence after drinking has stopped.[59] In practice, these medications are best used alongside behavioral treatment, follow-up, and attention to relapse risk rather than as stand-alone solutions.

Enhancing Healthcare Team Outcomes

Behavior change is usually more successful when supported by a multidisciplinary team. Physicians and advanced practitioners often help patients understand risk, connect behavior to health outcomes, and decide where to start (see Table 2). Registered nurses commonly reinforce those goals through follow-up, education, and troubleshooting. Pharmacists can help by optimizing medications that support change, including treatments for smoking cessation, weight management, and alcohol use disorder, and by simplifying regimens. Team-based models are especially effective in obesity and diabetes care, where dietary, behavioral, and pharmacologic support often work best together.[60]

Table

Table 2. Clinical Situations and Pathways for Self-Help and Referral.

Other team members often address barriers that may not fully surface during a brief office or hospital encounter. Dietitians can turn broad advice into practical, individualized eating plans. Behavioral health clinicians can help patients work through stress, depression, low motivation, or other psychological barriers.

Exercise professionals can tailor activity plans to a patient’s baseline function and limitations. Lifestyle medicine coaches can provide regular accountability, reinforcement between visits, and guidance in applying goals to daily routines. Social workers and community resources are equally important when cost, transportation, housing instability, or limited access to healthy food interfere with progress. Team communication also matters. Motivational interviewing outperforms traditional advice-giving across a range of behavioral conditions and provides a useful, common approach to counseling.[45] When patients receive clear, consistent messages from multiple team members, they are more likely to stay engaged and sustain change over time.[60]

Review Questions

• Access free multiple choice questions on this topic.
• Comment on this article.

References

1.

Rippe JM. Lifestyle Medicine: The Health Promoting Power of Daily Habits and Practices. Am J Lifestyle Med. 2018 Nov-Dec;12(6):499-512. [PMC free article: PMC6367881] [PubMed: 30783405]

2.

Spring B, Moller AC, Coons MJ. Multiple health behaviours: overview and implications. J Public Health (Oxf). 2012 Mar;34 Suppl 1(Suppl 1):i3-10. [PMC free article: PMC3284863] [PubMed: 22363028]

3.

King DE, Mainous AG, Carnemolla M, Everett CJ. Adherence to healthy lifestyle habits in US adults, 1988-2006. Am J Med. 2009 Jun;122(6):528-34. [PubMed: 19486715]

4.

Li Y, Pan A, Wang DD, Liu X, Dhana K, Franco OH, Kaptoge S, Di Angelantonio E, Stampfer M, Willett WC, Hu FB. Impact of Healthy Lifestyle Factors on Life Expectancies in the US Population. Circulation. 2018 Jul 24;138(4):345-355. [PMC free article: PMC6207481] [PubMed: 29712712]

5.

Stead M, Angus K, Langley T, Katikireddi SV, Hinds K, Hilton S, Lewis S, Thomas J, Campbell M, Young B, Bauld L. Mass media to communicate public health messages in six health topic areas: a systematic review and other reviews of the evidence. NIHR Journals Library; Southampton (UK): Apr, 2019. [PubMed: 31046212]

6.

Snyder LB. Health communication campaigns and their impact on behavior. J Nutr Educ Behav. 2007 Mar-Apr;39(2 Suppl):S32-40. [PubMed: 17336803]

7.

Kelly S, Martin S, Kuhn I, Cowan A, Brayne C, Lafortune L. Barriers and Facilitators to the Uptake and Maintenance of Healthy Behaviours by People at Mid-Life: A Rapid Systematic Review. PLoS One. 2016;11(1):e0145074. [PMC free article: PMC4731386] [PubMed: 26815199]

8.

Godin G, Kok G. The theory of planned behavior: a review of its applications to health-related behaviors. Am J Health Promot. 1996 Nov-Dec;11(2):87-98. [PubMed: 10163601]

9.

Faries MD. Why We Don't "Just Do It": Understanding the Intention-Behavior Gap in Lifestyle Medicine. Am J Lifestyle Med. 2016 Sep-Oct;10(5):322-329. [PMC free article: PMC6125069] [PubMed: 30202289]

10.

Hattar A, Pal S, Hagger MS. Predicting Physical Activity-Related Outcomes in Overweight and Obese Adults: A Health Action Process Approach. Appl Psychol Health Well Being. 2016 Mar;8(1):127-51. [PubMed: 26970113]

11.

Adriaanse MA, Vinkers CD, De Ridder DT, Hox JJ, De Wit JB. Do implementation intentions help to eat a healthy diet? A systematic review and meta-analysis of the empirical evidence. Appetite. 2011 Feb;56(1):183-93. [PubMed: 21056605]

12.

Silva MAVD, São-João TM, Brizon VC, Franco DH, Mialhe FL. Impact of implementation intentions on physical activity practice in adults: A systematic review and meta-analysis of randomized clinical trials. PLoS One. 2018;13(11):e0206294. [PMC free article: PMC6235272] [PubMed: 30427874]

13.

Hagger MS, Hardcastle SJ, Chater A, Mallett C, Pal S, Chatzisarantis NL. Autonomous and controlled motivational regulations for multiple health-related behaviors: between- and within-participants analyses. Health Psychol Behav Med. 2014 Jan 01;2(1):565-601. [PMC free article: PMC4346087] [PubMed: 25750803]

14.

Becker CM, Sewell K, Bian H, Lee JGL. Limited Improvements in Health Behaviors Suggest Need to Review Approaches to Health Promotion: A Repeated, Cross-Sectional Study. Am J Lifestyle Med. 2022 Jul-Aug;16(4):521-526. [PMC free article: PMC9290184] [PubMed: 35860371]

15.

Key TJ, Papier K, Tong TYN. Plant-based diets and long-term health: findings from the EPIC-Oxford study. Proc Nutr Soc. 2022 May;81(2):190-198. [PMC free article: PMC7613518] [PubMed: 35934687]

16.

Landry MJ, Ward CP. Health Benefits of a Plant-Based Dietary Pattern and Implementation in Healthcare and Clinical Practice. Am J Lifestyle Med. 2024 Sep-Oct;18(5):657-665. [PMC free article: PMC11412377] [PubMed: 39309320]

17.

Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H, Watts GF, Borén J, Fazio S, Horton JD, Masana L, Nicholls SJ, Nordestgaard BG, van de Sluis B, Taskinen MR, Tokgözoglu L, Landmesser U, Laufs U, Wiklund O, Stock JK, Chapman MJ, Catapano AL. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017 Aug 21;38(32):2459-2472. [PMC free article: PMC5837225] [PubMed: 28444290]

18.

Snetselaar LG, de Jesus JM, DeSilva DM, Stoody EE. Dietary Guidelines for Americans, 2020-2025: Understanding the Scientific Process, Guidelines, and Key Recommendations. Nutr Today. 2021 Nov-Dec;56(6):287-295. [PMC free article: PMC8713704] [PubMed: 34987271]

19.

Fontana L, Hu FB. Optimal body weight for health and longevity: bridging basic, clinical, and population research. Aging Cell. 2014 Jun;13(3):391-400. [PMC free article: PMC4032609] [PubMed: 24628815]

20.

Silverman MN, Deuster PA. Biological mechanisms underlying the role of physical fitness in health and resilience. Interface Focus. 2014 Oct 06;4(5):20140040. [PMC free article: PMC4142018] [PubMed: 25285199]

21.

Piercy KL, Troiano RP. Physical Activity Guidelines for Americans From the US Department of Health and Human Services. Circ Cardiovasc Qual Outcomes. 2018 Nov;11(11):e005263. [PubMed: 30571339]

22.

Sleet DA, Scarbrough W, Brown C, Bizzell A. Alcohol Harms, Injuries, and Health: Clinical Implications for Lifestyle Medicine. Am J Lifestyle Med. 2025 Jul 11;20(3):15598276251350863. [PMC free article: PMC12254130] [PubMed: 40655040]

23.

Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998 Sep 14;158(16):1789-95. [PubMed: 9738608]

24.

Barbería-Latasa M, Gea A, Martínez-González MA. Alcohol, Drinking Pattern, and Chronic Disease. Nutrients. 2022 May 07;14(9) [PMC free article: PMC9100270] [PubMed: 35565924]

25.

GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018 Sep 22;392(10152):1015-1035. [PMC free article: PMC6148333] [PubMed: 30146330]

26.

Munro S, Lewin S, Swart T, Volmink J. A review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? BMC Public Health. 2007 Jun 11;7:104. [PMC free article: PMC1925084] [PubMed: 17561997]

27.

Alhamad H, Donyai P. The Validity of the Theory of Planned Behaviour for Understanding People's Beliefs and Intentions toward Reusing Medicines. Pharmacy (Basel). 2021 Mar 09;9(1) [PMC free article: PMC8006004] [PubMed: 33803406]

28.

Francis JJ, O'Connor D, Curran J. Theories of behaviour change synthesised into a set of theoretical groupings: introducing a thematic series on the theoretical domains framework. Implement Sci. 2012 Apr 24;7:35. [PMC free article: PMC3444902] [PubMed: 22531601]

29.

Gardner B, Lally P, Wardle J. Making health habitual: the psychology of 'habit-formation' and general practice. Br J Gen Pract. 2012 Dec;62(605):664-6. [PMC free article: PMC3505409] [PubMed: 23211256]

30.

Phillips LA, More KR. Evaluating behavior change factors over time for a simple vs. complex health behavior. Front Psychol. 2022;13:962150. [PMC free article: PMC9499174] [PubMed: 36160596]

31.

Singh B, Murphy A, Maher C, Smith AE. Time to Form a Habit: A Systematic Review and Meta-Analysis of Health Behaviour Habit Formation and Its Determinants. Healthcare (Basel). 2024 Dec 09;12(23) [PMC free article: PMC11641623] [PubMed: 39685110]

32.

Sheeran P, Wright CE, Avishai A, Villegas ME, Lindemans JW, Klein WMP, Rothman AJ, Miles E, Ntoumanis N. Self-determination theory interventions for health behavior change: Meta-analysis and meta-analytic structural equation modeling of randomized controlled trials. J Consult Clin Psychol. 2020 Aug;88(8):726-737. [PubMed: 32437175]

33.

Harrison JA, Mullen PD, Green LW. A meta-analysis of studies of the Health Belief Model with adults. Health Educ Res. 1992 Mar;7(1):107-16. [PubMed: 10148735]

34.

Schwarzer R, Renner B. Social-cognitive predictors of health behavior: action self-efficacy and coping self-efficacy. Health Psychol. 2000 Sep;19(5):487-95. [PubMed: 11007157]

35.

Zhang CQ, Zhang R, Schwarzer R, Hagger MS. A meta-analysis of the health action process approach. Health Psychol. 2019 Jul;38(7):623-637. [PubMed: 30973747]

36.

Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997 Sep-Oct;12(1):38-48. [PubMed: 10170434]

37.

Hettema J, Steele J, Miller WR. Motivational interviewing. Annu Rev Clin Psychol. 2005;1:91-111. [PubMed: 17716083]

38.

Smith AW, Borowski LA, Liu B, Galuska DA, Signore C, Klabunde C, Huang TT, Krebs-Smith SM, Frank E, Pronk N, Ballard-Barbash R. U.S. primary care physicians' diet-, physical activity-, and weight-related care of adult patients. Am J Prev Med. 2011 Jul;41(1):33-42. [PMC free article: PMC3142674] [PubMed: 21665061]

39.

McKenna J, Naylor PJ, McDowell N. Barriers to physical activity promotion by general practitioners and practice nurses. Br J Sports Med. 1998 Sep;32(3):242-7. [PMC free article: PMC1756103] [PubMed: 9773175]

40.

Bouton ME. Why behavior change is difficult to sustain. Prev Med. 2014 Nov;68:29-36. [PMC free article: PMC4287360] [PubMed: 24937649]

41.

Stonerock GL, Blumenthal JA. Role of Counseling to Promote Adherence in Healthy Lifestyle Medicine: Strategies to Improve Exercise Adherence and Enhance Physical Activity. Prog Cardiovasc Dis. 2017 Mar-Apr;59(5):455-462. [PMC free article: PMC5350064] [PubMed: 27640186]

42.

Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM., Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 Feb 07;346(6):393-403. [PMC free article: PMC1370926] [PubMed: 11832527]

43.

Echouffo-Tcheugui JB, Perreault L, Ji L, Dagogo-Jack S. Diagnosis and Management of Prediabetes: A Review. JAMA. 2023 Apr 11;329(14):1206-1216. [PubMed: 37039787]

44.

Tate C. Behavioral Approaches to Nutrition Counseling in the Primary Care Setting. Med Clin North Am. 2022 Sep;106(5):809-818. [PubMed: 36154701]

45.

Rubak S, Sandbaek A, Lauritzen T, Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract. 2005 Apr;55(513):305-12. [PMC free article: PMC1463134] [PubMed: 15826439]

46.

Rahimi F, Massoudifar A, Rahimi R. Smoking cessation pharmacotherapy; varenicline or bupropion? Daru. 2024 Dec;32(2):901-906. [PMC free article: PMC11555175] [PubMed: 39264407]

47.

Skinner K, Clements J. Current clinical application of incretin therapy for obesity management. Can J Physiol Pharmacol. 2026 Jan 01;104:1-8. [PubMed: 41420876]

48.

Bonga KN, Padhan M. Incretin Analogues for Weight Reduction in Non-Diabetic Obese: A Review of Liraglutide, Semaglutide, and Tirzepatide Beyond Glycemic Control. Rambam Maimonides Med J. 2026 Jan 28;17(1) [PMC free article: PMC12857648] [PubMed: 41605830]

49.

Buch A, Eldor R, Brown R, Zonszein J. Novel oral agents in anti-obesity pharmacotherapy: A narrative review. Diabetes Obes Metab. 2025 Oct;27(10):5409-5417. [PubMed: 40662383]

50.

Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF., STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18;384(11):989-1002. [PubMed: 33567185]

51.

Fernández-Fígares Jiménez MDC. A Whole Plant-Foods Diet in the Prevention and Treatment of Overweight and Obesity: From Empirical Evidence to Potential Mechanisms. J Am Nutr Assoc. 2025 Feb;44(2):137-155. [PubMed: 39401341]

52.

Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, Lingvay I, McGowan BM, Oral TK, Rosenstock J, Wadden TA, Wharton S, Yokote K, Kushner RF., STEP 1 Study Group. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022 Aug;24(8):1553-1564. [PMC free article: PMC9542252] [PubMed: 35441470]

53.

Virdis A, Giannarelli C, Neves MF, Taddei S, Ghiadoni L. Cigarette smoking and hypertension. Curr Pharm Des. 2010;16(23):2518-25. [PubMed: 20550499]

54.

Sahle BW, Chen W, Rawal LB, Renzaho AMN. Weight Gain After Smoking Cessation and Risk of Major Chronic Diseases and Mortality. JAMA Netw Open. 2021 Apr 01;4(4):e217044. [PMC free article: PMC8080225] [PubMed: 33904915]

55.

Chao AM, Wadden TA, Ashare RL, Loughead J, Schmidt HD. Tobacco Smoking, Eating Behaviors, and Body Weight: A Review. Curr Addict Rep. 2019;6:191-199. [PMC free article: PMC7678013] [PubMed: 33224710]

56.

Aubin HJ, Farley A, Lycett D, Lahmek P, Aveyard P. Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ. 2012 Jul 10;345:e4439. [PMC free article: PMC3393785] [PubMed: 22782848]

57.

Hajizadeh A, Howes S, Theodoulou A, Klemperer E, Hartmann-Boyce J, Livingstone-Banks J, Lindson N. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2023 May 24;5(5):CD000031. [PMC free article: PMC10207863] [PubMed: 37230961]

58.

Wu P, Wilson K, Dimoulas P, Mills EJ. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health. 2006 Dec 11;6:300. [PMC free article: PMC1764891] [PubMed: 17156479]

59.

Kranzler HR, Soyka M. Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. JAMA. 2018 Aug 28;320(8):815-824. [PMC free article: PMC7391072] [PubMed: 30167705]

60.

Foster D, Sanchez-Collins S, Cheskin LJ. Multidisciplinary Team-Based Obesity Treatment in Patients With Diabetes: Current Practices and the State of the Science. Diabetes Spectr. 2017 Nov;30(4):244-249. [PMC free article: PMC5687103] [PubMed: 29151714]

Disclosure: Santiago Espinosa-Salas declares no relevant financial relationships with ineligible companies.

Disclosure: Daniel Keyes declares no relevant financial relationships with ineligible companies.

Disclosure: Mauricio Gonzalez-Arias declares no relevant financial relationships with ineligible companies.